Oliver Lagore Vanvalin Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $514K | Buy |
+2,454
| New | +$514K | 0.2% | 91 |
|
|
2024
Q4 | $26.1K | Buy |
147
+25
| +20% | +$4.44K | 0.01% | 328 |
|
|
2024
Q3 | $24.1K | Sell |
122
-30
| -20% | -$5.93K | 0.01% | 325 |
|
|
2024
Q2 | $26.1K | Sell |
152
-34
| -18% | -$5.83K | 0.01% | 307 |
|
|
2024
Q1 | $33.9K | Sell |
186
-35
| -16% | -$6.37K | 0.01% | 274 |
|
|
2023
Q4 | $34.2K | Sell |
221
-104
| -32% | -$16.1K | 0.01% | 247 |
|
|
2023
Q3 | $48.4K | Buy |
325
+39
| +14% | +$5.81K | 0.02% | 243 |
|
|
2023
Q2 | $38.5K | Buy |
286
+6
| +2% | +$808 | 0.01% | 278 |
|
|
2023
Q1 | $44.6K | Sell |
280
-24
| -8% | -$3.83K | 0.02% | 197 |
|
|
2022
Q4 | $49.1K | Buy |
304
+102
| +50% | +$16.5K | 0.03% | 180 |
|
|
2022
Q3 | $27K | Buy |
202
+93
| +85% | +$12.4K | 0.02% | 222 |
|
|
2022
Q2 | $17K | Hold |
109
| – | – | 0.01% | 271 |
|
|
2022
Q1 | $17K | Buy |
+109
| New | +$17K | 0.01% | 268 |
|